AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vilgud-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Norgam Medicaments Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vilgud-M 1 Tablet SR

Diabetil-Duo 1mg Extended-Release Tablet combines two active ingredients to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetil-Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose readings, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing, at the same time each day, maximizes therapeutic benefit; discontinuation should only occur under physician supervision. Effective blood sugar control contributes to the prevention of future complications. Maintaining the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts disease control. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential adverse effect when used with insulin or sulfonylureas, requires patient awareness and appropriate management strategies. This medication isn't suitable for all individuals. Prior to commencing treatment, patients should disclose any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Drug interactions are possible; therefore, comprehensive disclosure of all medications is essential for safe use. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Renal function and blood glucose levels will be monitored by your physician throughout treatment.

Primary Ingredients of Vilgud-M 1 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Vilgud-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Vilgud-M 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Vilgud-M 1 Tablet SR with a meal.

Common Side effects of Vilgud-M 1 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilgud-M 1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. It's recommended to take Vilgud-M 1 Tablet SR with a meal.

How Vilgud-M 1 Tablet SR works:

One sustained-release Vilgud-M tablet combines two antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Vilgud-M 1 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vilgud-M 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vilgud-M 1 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vilgud-M 1 Tablet SR. A modified dosage of Vilgud-M 1 Tablet SR may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Vilgud-M 1 Tablet SR is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Vilgud-M 1 Tablet SR :

Should you forget a dose of Vilgud-M 1 Tablet SR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vilgud-M 1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vilgud-M 1 Tablet SR

Vilgud-M 1 Tablet SR rarely causes hypoglycemia by itself; however, insufficient caloric intake while using it can lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vilgud-M 1 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Vilgud-M 1 Tablet SR is contraindicated in patients allergic to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vilgud-M 1 Tablet SR combines metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Viligud-M 1 Tablet SR can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving excessive blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users, hence its avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vilgud-M 1 Tablet SR immediately and seek urgent medical attention.
Prolonged Vilgud-M 1 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vilgud-M 1 Tablet SR as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Vilgud-M 1 Tablet SR
74
MRP 86
13% off